Close Menu

NEW YORK – Newborn and pediatric testing firm Baebies announced on Tuesday it has applied CE marking to its Finder platform for glucose-6-phosphate dehydrogenase testing.

The Durham, North Carolina firm applied the CE mark to the Finder instrument and cartridge, which includes tests for G6PD from a drop of whole blood. The near-patient platform has a turnaround time of about 15 minutes after sample introduction, it said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.